MINI FUTURE LONG - COOPER COMPANIES Share Price

Certificat

DE000MG3BBU5

Market Closed - Börse Stuttgart 20:56:36 19/06/2024 BST
0.237 EUR -2.87% Intraday chart for MINI FUTURE LONG - COOPER COMPANIES
Current month-9.63%
1 month-15.86%
Date Price Change
19/06/24 0.237 -2.87%
18/06/24 0.244 -2.40%
17/06/24 0.25 -3.85%
14/06/24 0.26 -3.70%
13/06/24 0.27 0.00%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 08:56 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG3BBU
ISINDE000MG3BBU5
Date issued 30/04/2024
Strike 65.7 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.3
Lowest since issue 0.226

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
91.66 USD
Average target price
108.2 USD
Spread / Average Target
+18.00%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW